• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Neoadjuvant chemotherapy for bladder cancer: Two decades on.

作者信息

Nayyar Rishi

机构信息

Department of Urology, All India Institute of Medical Sciences, New Delhi, India.

出版信息

Indian J Urol. 2025 Jan-Mar;41(1):1-2. doi: 10.4103/iju.iju_432_24. Epub 2025 Jan 1.

DOI:10.4103/iju.iju_432_24
PMID:39886629
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11778688/
Abstract
摘要

相似文献

1
Neoadjuvant chemotherapy for bladder cancer: Two decades on.膀胱癌的新辅助化疗：二十年回顾。
Indian J Urol. 2025 Jan-Mar;41(1):1-2. doi: 10.4103/iju.iju_432_24. Epub 2025 Jan 1.
2
Effect of neoadjuvant chemotherapy on health-related quality of life in patients with muscle-invasive bladder cancer: results from JCOG0209, a randomized phase III study.新辅助化疗对肌层浸润性膀胱癌患者健康相关生活质量的影响：来自 JCOG0209 的随机 III 期研究结果。
Jpn J Clin Oncol. 2020 Dec 16;50(12):1464-1469. doi: 10.1093/jjco/hyaa123.
3
Discerning Patterns and Quality of Neoadjuvant Chemotherapy Use Among Patients with Muscle-invasive Bladder Cancer.鉴别肌层浸润性膀胱癌患者新辅助化疗的应用模式和质量。
Eur Urol Oncol. 2019 Sep;2(5):497-504. doi: 10.1016/j.euo.2018.07.009. Epub 2018 Aug 17.
4
Potential therapeutic effects of adjuvant chemotherapy after neoadjuvant chemotherapy for locally advanced muscle-invasive bladder cancer.新辅助化疗后辅助化疗治疗局部晚期肌层浸润性膀胱癌的潜在疗效。
Jpn J Clin Oncol. 2022 Apr 6;52(4):388-396. doi: 10.1093/jjco/hyab210.
5
Retrospective analysis of the efficacy of two cycles of M-VAC neoadjuvant chemotherapy followed by radical cystectomy for muscle-invasive bladder cancer.回顾性分析两周期 M-VAC 新辅助化疗后行根治性膀胱切除术治疗肌层浸润性膀胱癌的疗效。
Anticancer Res. 2013 Oct;33(10):4497-503.
6
A Retrospective Analysis of the Effect on Survival of Time from Diagnosis to Neoadjuvant Chemotherapy to Cystectomy for Muscle Invasive Bladder Cancer.从诊断到新辅助化疗再到根治性膀胱切除术的时间对肌层浸润性膀胱癌患者生存影响的回顾性分析
J Urol. 2016 Apr;195(4 Pt 1):880-5. doi: 10.1016/j.juro.2015.11.024. Epub 2015 Nov 18.
7
The utility of neoadjuvant gemcitabine plus carboplatin followed by immediate radical cystectomy in patients with muscle-invasive bladder cancer who are ineligible for cisplatin-based chemotherapy.对于不符合基于顺铂化疗条件的肌层浸润性膀胱癌患者，新辅助吉西他滨联合卡铂治疗后立即进行根治性膀胱切除术的效用。
Int J Clin Oncol. 2017 Feb;22(1):159-165. doi: 10.1007/s10147-016-1029-2. Epub 2016 Aug 17.
8
Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Systematic Review and Two-Step Meta-Analysis.肌肉浸润性膀胱癌的新辅助化疗：系统评价和两步荟萃分析
Oncologist. 2016 Jun;21(6):708-15. doi: 10.1634/theoncologist.2015-0440. Epub 2016 Apr 6.
9
Trimodality Therapy With or Without Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer.三模态疗法联合或不联合新辅助化疗治疗肌层浸润性膀胱癌。
Clin Genitourin Cancer. 2021 Aug;19(4):362-368. doi: 10.1016/j.clgc.2021.03.007. Epub 2021 Mar 16.
10
Impact of neoadjuvant chemotherapy on survival and recurrence patterns after robot-assisted radical cystectomy for muscle-invasive bladder cancer: Results from the International Robotic Cystectomy Consortium.新辅助化疗对机器人辅助根治性膀胱切除术治疗肌层浸润性膀胱癌患者生存和复发模式的影响：来自国际机器人膀胱切除术联盟的结果。
Int J Urol. 2022 Mar;29(3):197-205. doi: 10.1111/iju.14749. Epub 2021 Dec 19.

本文引用的文献

1
Standard or Extended Lymphadenectomy for Muscle-Invasive Bladder Cancer.标准或扩大淋巴结切除术治疗肌层浸润性膀胱癌。
N Engl J Med. 2024 Oct 3;391(13):1206-1216. doi: 10.1056/NEJMoa2401497.
2
A 3-arm randomized control trial to compare the efficacy of re-circulant hyperthermic intravesical chemotherapy versus conventional intravesical mitomycin C and BCG therapy for intermediate-risk non-muscle invasive bladder cancer.一项三臂随机对照试验，旨在比较循环式高热膀胱内化疗与常规膀胱内丝裂霉素 C 和卡介苗治疗中危非肌层浸润性膀胱癌的疗效。
World J Urol. 2024 Oct 31;42(1):609. doi: 10.1007/s00345-024-05338-x.
3
Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER): survival endpoints at 5 years in an open-label, randomised, phase 3 study.肌层浸润性膀胱癌中围手术期密集剂量甲氨蝶呤、长春碱、阿霉素和顺铂（VESPER）：一项开放标签、随机、3 期研究的 5 年生存终点。
Lancet Oncol. 2024 Feb;25(2):255-264. doi: 10.1016/S1470-2045(23)00587-9. Epub 2023 Dec 21.
4
The Role of Neoadjuvant Chemotherapy in Bladder Preservation Approaches in Muscle-Invasive Bladder Cancer.新辅助化疗在肌层浸润性膀胱癌保膀胱治疗中的作用。
Semin Radiat Oncol. 2023 Jan;33(1):51-55. doi: 10.1016/j.semradonc.2022.10.006.
5
Neoadjuvant immunotherapy, chemotherapy, and combination therapy in muscle-invasive bladder cancer: A multi-center real-world retrospective study.新辅助免疫治疗、化疗和联合治疗在肌层浸润性膀胱癌中的应用：一项多中心真实世界回顾性研究。
Cell Rep Med. 2022 Nov 15;3(11):100785. doi: 10.1016/j.xcrm.2022.100785. Epub 2022 Oct 19.
6
Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma.纳武利尤单抗辅助治疗与安慰剂用于肌肉浸润性尿路上皮癌。
N Engl J Med. 2021 Jun 3;384(22):2102-2114. doi: 10.1056/NEJMoa2034442.
7
Meta-analysis of neoadjuvant chemotherapy compared to radical cystectomy alone in improving overall survival of muscle-invasive bladder cancer patients.新辅助化疗对比单纯根治性膀胱切除术改善肌层浸润性膀胱癌患者总生存的荟萃分析。
BMC Urol. 2020 Oct 14;20(1):158. doi: 10.1186/s12894-020-00733-z.
8
Effect of neoadjuvant chemotherapy in patients undergoing radical cystectomy for muscle-invasive bladder cancer: a retrospective, multi-institutional study.新辅助化疗对肌层浸润性膀胱癌根治性膀胱切除术患者的影响：一项回顾性、多机构研究。
Jpn J Clin Oncol. 2020 Jan 24;50(1):73-79. doi: 10.1093/jjco/hyz137.
9
Neoadjuvant treatment for muscle-invasive bladder cancer: The past, the present, and the future.肌肉浸润性膀胱癌的新辅助治疗：过去、现在与未来。
Urol Oncol. 2018 Sep;36(9):413-422. doi: 10.1016/j.urolonc.2017.10.014. Epub 2017 Nov 8.
10
Eligibility for neoadjuvant/adjuvant cisplatin-based chemotherapy among radical cystectomy patients.根治性膀胱切除术患者接受新辅助/辅助顺铂化疗的资格。
BJU Int. 2014 May;113(5b):E17-21. doi: 10.1111/bju.12274. Epub 2013 Sep 5.